Detalhe da pesquisa
1.
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL.
Mol Syst Biol
; 18(8): e10855, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35959629
2.
The protein landscape of chronic lymphocytic leukemia.
Blood
; 138(24): 2514-2525, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34189564
3.
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Blood
; 134(21): 1821-1831, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527074
4.
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia.
Nat Commun
; 13(1): 6226, 2022 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266272
5.
Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia.
Nat Cancer
; 2(8): 853-864, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423310
6.
Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library Screens.
Methods Mol Biol
; 1956: 351-362, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779044
7.
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
Cancer Res
; 79(12): 3125-3138, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31000522
8.
SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues.
Leuk Res
; 107: 106608, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33979727